Lv21
146 积分 2025-01-03 加入
Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study
5小时前
待确认
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multi-center Cohort Study
5小时前
已完结
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study
4天前
已完结
Autophagy-dependent hepatocyte apoptosis mediates gilteritinib-induced hepatotoxicity
21天前
已完结
A Case of Acute Myeloid Leukemia with an FMS-like Tyrosine Kinase 3-tyrosine Kinase Domain Mutation Developing Gilteritinib-induced Differentiation Syndrome
21天前
已关闭
Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis
21天前
已完结
Three-year follow-up of low-dose, early-start gilteritinib maintenance in posttransplant patients with R/R FLT3mut AML
27天前
已完结
Dynamic evolution of venetoclax resistance in acute myeloid leukemia unveiled by longitudinal single-cell RNA-seq
27天前
已完结
Clonal haematopoiesis to clonal cytopenias: unravelling disease evolution over time
1个月前
已关闭
Advances in menin inhibition in acute myeloid leukemia
2个月前
已完结
皖公网安备34019202002308
